I wish these articles wouldn't turn up here. Although this sounds cool, the chance of having an impact on actual patient care is miniscule. This is a very compl

I wish these articles wouldn't turn up here. Although this sounds cool, the chance of having an impact on actual patient care is miniscule. This is a very complcated delivery system at the end of the day. We have enough trouble giving one drug and managing toxicity successfully, let alone this controlled nano infection cocktail. Also hypoxia isn't as tumour specific as you think, off target toxicity is a problem. I don't think anyone will be cured by this and it will no doubt cost an absolute fortune.